Skip to main content

AlphaMark Advisors, LLC

SEC CIK
0001348183
Latest filing
Jan 21, 2025

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by AlphaMark Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q4 2024 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2024
Holdings of HALO by AlphaMark Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−5,675−100.0%Sold outHolders
Q3 20245,675$325.0K0.1%+5,675NewHolders